531569 logo

Sanjivani Paranteral Limited Stock Price

BSE:531569 Community·₹2.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

531569 Share Price Performance

₹214.85
-77.30 (-26.46%)
₹214.85
-77.30 (-26.46%)
Price ₹214.85

531569 Community Narratives

There are no narratives available yet.

Recent 531569 News & Updates

Sanjivani Paranteral Limited Key Details

₹715.5m

Revenue

₹413.4m

Cost of Revenue

₹302.2m

Gross Profit

₹221.1m

Other Expenses

₹81.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.60
Gross Margin
42.23%
Net Profit Margin
11.34%
Debt/Equity Ratio
20.4%

Sanjivani Paranteral Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record.

2 Risks
1 Reward

About 531569

Founded
1994
Employees
40
CEO
Ashwani Khemka
WebsiteView website
www.sanjivani.co.in

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Indian Market Performance

  • 7 Days: 0.9%
  • 3 Months: 0.1%
  • 1 Year: -4.1%
  • Year to Date: 1.6%
The Information Technology sector gained 3.8% while the market remained flat over the last week. The past year hasn't been profitable, with the market dropping 4.1%. Looking forward, earnings are forecast to grow by 16% annually. Market details ›